Video Library - Personalized Medicine
Andrew Stainthorpe, PhD
Oncologists should be guided by the research that is being done around outcomes, benefit, and society impact when making value-based care decisions, says Dr. Stainthorpe.
Related Items
Precision Medicine the Future of Cancer Care, but Cost Remains a Major Barrier
David Knight
December 2016 Vol 9, Special Issue: Payers’ Perspectives In Oncology: AVBCC 2016 Highlights published on December 28, 2016 in Personalized Medicine
Genomic Assays Expediting Adoption of Personalized Cancer Therapy in Clinical Practice
Wayne Kuznar
December 2016 Vol 9, Special Issue: Payers’ Perspectives In Oncology: AVBCC 2016 Highlights published on December 28, 2016 in Personalized Medicine
A New Paradigm Matching Targeted Therapy to Molecular Alterations Independent of Tumor Type
Phoebe Starr
August 2016 Vol 9, Special Issue: Payers' Perspectives in Oncology published on August 15, 2016 in Personalized Medicine
Gene-Expression Signature Validated as Prognostic Marker in Stage II Colon Cancer
Alice Goodman
August 2016 Vol 9, Special Issue: Payers' Perspectives in Oncology published on August 15, 2016 in Personalized Medicine
ASCO and NCI Launch Largest Precision Medicine Trials Using Real-World Evidence
Audrey Andrews
August 2015 Vol 8, Special Issue: Payers' Perspectives in Oncology published on August 18, 2015 in Personalized Medicine
Last modified: March 24, 2015
  •  Association for Value-Based Cancer Care
  • Value-Based Cancer Care
  • Value-Based Care in Rheumatology
  • Oncology Practice Management
  • Rheumatology Practice Management
  • Urology Practice Management
  • Inside Patient Care: Pharmacy & Clinic
  • Lynx CME